TCR2 Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.90
|
|
Average Rating
|
3.89
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.83
|
-0.79
|
0.04
|
4.82%
|
|
2022-06-30
|
-0.79
|
-0.82
|
-0.03
|
-3.80%
|
|
2022-03-31
|
-0.74
|
-0.76
|
-0.02
|
-2.70%
|
|
2021-12-31
|
-0.75
|
-0.72
|
0.03
|
4.00%
|
|
2021-09-30
|
-0.65
|
-0.69
|
-0.04
|
-6.15%
|
|
2021-06-30
|
-0.59
|
-0.64
|
-0.05
|
-8.47%
|
|
2021-03-31
|
-0.53
|
-0.58
|
-0.05
|
-9.43%
|
|
2020-12-31
|
-0.56
|
-0.55
|
0.01
|
1.79%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.37
|
|
2021-12-31
|
-2.63
|
|
2020-12-31
|
-2.43
|
|
2019-12-31
|
-6.43
|
|
2018-12-31
|
-16.22
|